Vipul Jairath

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 281 citations · Full text

Veterinary Medicine, Immunology, Gastroenterology +16

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

Vipul Jairath, Reena Khanna, Guangyong Zou et al. · Alimentary Pharmacology & Therapeutics · 2015 · 173 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Parambir S. Dulai, Brigid S. Boland, Siddharth Singh et al. · Gastroenterology · 2018 · 149 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

Bruce E. Sands, Laurent Peyrin‐Biroulet, Jarosław Kierkuś et al. · Gastroenterology · 2021 · 149 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +12

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials

Brennan C Kahan, Suzie Cro, Caroline J Doré et al. · Trials · 2014 · 116 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16